Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1200

1.

A comparison of metrics and performance characteristics of different search strategies for article retrieval for a systematic review of the global epidemiology of kidney and urinary diseases.

Bikbov B, Perico N, Remuzzi G; GBD Genitourinary Diseases Expert Group.

BMC Med Res Methodol. 2018 Oct 19;18(1):110. doi: 10.1186/s12874-018-0569-8.

2.

Mesenchymal stromal cells in kidney transplantation.

Casiraghi F, Remuzzi G.

Curr Opin Nephrol Hypertens. 2018 Oct 8. doi: 10.1097/MNH.0000000000000461. [Epub ahead of print]

PMID:
30300159
3.

Maternal and environmental risk factors for neonatal AKI and its long-term consequences.

Perico N, Askenazi D, Cortinovis M, Remuzzi G.

Nat Rev Nephrol. 2018 Nov;14(11):688-703. doi: 10.1038/s41581-018-0054-y. Review.

PMID:
30224767
4.

Kidney Disease.

Anand S, Thomas B, Remuzzi G, Riella M, Nahas ME, Naicker S, Dirks J.

In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 13.

5.

Addressing acute kidney injury in critically ill newborn babies.

Perico N, Remuzzi G.

Lancet Child Adolesc Health. 2017 Nov;1(3):161-163. doi: 10.1016/S2352-4642(17)30071-8. Epub 2017 Sep 8. No abstract available.

PMID:
30169159
6.

Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care.

Borrelli S, Chiodini P, De Nicola L, Minutolo R, Provenzano M, Garofalo C, Remuzzi G, Ronco C, Cozzolino MG, Manno C, Costanzo AM, Gualberti G, Conte G.

PLoS One. 2018 Aug 23;13(8):e0202417. doi: 10.1371/journal.pone.0202417. eCollection 2018.

7.

Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA.

Selby NM, Blankestijn PJ, Boor P, Combe C, Eckardt KU, Eikefjord E, Garcia-Fernandez N, Golay X, Gordon I, Grenier N, Hockings PD, Jensen JD, Joles JA, Kalra PA, Krämer BK, Mark PB, Mendichovszky IA, Nikolic O, Odudu A, Ong ACM, Ortiz A, Pruijm M, Remuzzi G, Rørvik J, de Seigneux S, Simms RJ, Slatinska J, Summers P, Taal MW, Thoeny HC, Vallée JP, Wolf M, Caroli A, Sourbron S.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii4-ii14. doi: 10.1093/ndt/gfy152.

8.

Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.

Rota C, Morigi M, Cerullo D, Introna M, Colpani O, Corna D, Capelli C, Rabelink TJ, Leuning DG, Rottoli D, Benigni A, Zoja C, Remuzzi G.

Stem Cell Res Ther. 2018 Aug 14;9(1):220. doi: 10.1186/s13287-018-0960-8.

9.

SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Cassis P, Locatelli M, Cerullo D, Corna D, Buelli S, Zanchi C, Villa S, Morigi M, Remuzzi G, Benigni A, Zoja C.

JCI Insight. 2018 Aug 9;3(15). pii: 98720. doi: 10.1172/jci.insight.98720. [Epub ahead of print]

10.

Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery.

Benedetti V, Brizi V, Guida P, Tomasoni S, Ciampi O, Angeli E, Valbusa U, Benigni A, Remuzzi G, Xinaris C.

EBioMedicine. 2018 Jul;33:253-268. doi: 10.1016/j.ebiom.2018.06.005. Epub 2018 Jul 3.

11.

Quantitation of the monoclonal antibody Denosumab by bioassay and validated LC methods.

Perobelli RF, Xavier B, Silveira ARD, Remuzzi GL, Motta LGJ, Dalmora SL.

Int J Biol Macromol. 2018 Nov;119:96-104. doi: 10.1016/j.ijbiomac.2018.07.120. Epub 2018 Jul 23.

PMID:
30048724
12.

Outrageous prices of orphan drugs: a call for collaboration.

Luzzatto L, Hyry HI, Schieppati A, Costa E, Simoens S, Schaefer F, Roos JCP, Merlini G, Kääriäinen H, Garattini S, Hollak CE, Remuzzi G; Second Workshop on Orphan Drugs participants.

Lancet. 2018 Sep 1;392(10149):791-794. doi: 10.1016/S0140-6736(18)31069-9. Epub 2018 Jul 20. No abstract available.

PMID:
30037734
13.

Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.

Cozzolino M, Bolasco P, Ronco C, Conte G, Menè P, Mereu MC, Di Luca M, Roccatello D, Rosati A, Jommi C, Costanzo AM, Gualberti G, di Luzio Paparatti U, Remuzzi G.

Nephron. 2018;140(1):39-47. doi: 10.1159/000490769. Epub 2018 Jul 17.

PMID:
30016767
14.

Toward longitudinal studies of hemodynamically induced vessel wall remodeling.

Bozzetto M, Brambilla P, Rota S, Ene-Iordache B, Sironi S, Remuzzi G, Remuzzi A.

Int J Artif Organs. 2018 Nov;41(11):714-722. doi: 10.1177/0391398818784207. Epub 2018 Jul 12.

PMID:
29998758
15.

ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental Diabetes.

Cassis P, Cerullo D, Zanchi C, Corna D, Lionetti V, Giordano F, Novelli R, Conti S, Casieri V, Matteucci M, Locatelli M, Taraboletti G, Villa S, Gastoldi S, Remuzzi G, Benigni A, Zoja C.

Diabetes. 2018 Oct;67(10):2069-2083. doi: 10.2337/db17-1508. Epub 2018 Jul 5.

PMID:
29976618
16.

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Perico N, Casiraghi F, Todeschini M, Cortinovis M, Gotti E, Portalupi V, Mister M, Gaspari F, Villa A, Fiori S, Introna M, Longhi E, Remuzzi G.

Front Immunol. 2018 Jun 14;9:1359. doi: 10.3389/fimmu.2018.01359. eCollection 2018.

17.

The role of B7-1 in proteinuria of glomerular origin.

Novelli R, Benigni A, Remuzzi G.

Nat Rev Nephrol. 2018 Sep;14(9):589-596. doi: 10.1038/s41581-018-0037-z. Review.

PMID:
29959373
18.

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Noris M, Donadelli R, Remuzzi G.

Pediatr Nephrol. 2018 Jun 9. doi: 10.1007/s00467-018-3989-0. [Epub ahead of print] Review.

PMID:
29948306
19.

Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study.

Bikbov B, Perico N, Remuzzi G; on behalf of the GBD Genitourinary Diseases Expert Group.

Nephron. 2018;139(4):313-318. doi: 10.1159/000489897. Epub 2018 May 23.

20.

Safety of Iohexol Administration to Measure Glomerular Filtration Rate in Different Patient Populations: A 25-Year Experience.

Gaspari F, Thakar S, Carrara F, Perna A, Trillini M, Aparicio MC, Diadei O, Ferrari S, Cannata A, Stucchi N, Ruggenenti P, Remuzzi G, Perico N.

Nephron. 2018;140(1):1-8. doi: 10.1159/000489898. Epub 2018 May 17.

PMID:
29772565
21.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

van Zuydam NR, Ahlqvist E, Sandholm N, Deshmukh H, Rayner NW, Abdalla M, Ladenvall C, Ziemek D, Fauman E, Robertson NR, McKeigue PM, Valo E, Forsblom C, Harjutsalo V; Finnish Diabetic Nephropathy Study (FinnDiane), Perna A, Rurali E, Marcovecchio ML, Igo RP Jr, Salem RM, Perico N, Lajer M, Käräjämäki A, Imamura M, Kubo M, Takahashi A, Sim X, Liu J, van Dam RM, Jiang G, Tam CHT, Luk AOY, Lee HM, Lim CKP, Szeto CC, So WY, Chan JCN; Hong Kong Diabetes Registry Theme-based Research Scheme Project Group, Ang SF, Dorajoo R, Wang L, Clara TSH, McKnight AJ, Duffy S; Warren 3 and Genetics of Kidneys in Diabetes (GoKinD) Study Group, Pezzolesi MG; GENIE (GEnetics of Nephropathy an International Effort) Consortium, Marre M, Gyorgy B, Hadjadj S, Hiraki LT; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Ahluwalia TS, Almgren P, Schulz CA, Orho-Melander M, Linneberg A, Christensen C, Witte DR, Grarup N, Brandslund I, Melander O, Paterson AD, Tregouet D, Maxwell AP, Lim SC, Ma RCW, Tai ES, Maeda S, Lyssenko V, Tuomi T, Krolewski AS, Rich SS, Hirschhorn JN, Florez JC, Dunger D, Pedersen O, Hansen T, Rossing P, Remuzzi G; SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, Brosnan MJ, Palmer CNA, Groop PH, Colhoun HM, Groop LC, McCarthy MI.

Diabetes. 2018 Jul;67(7):1414-1427. doi: 10.2337/db17-0914. Epub 2018 Apr 27.

PMID:
29703844
22.

Blood Pressure and Metabolic Effects of Acetyl-l-Carnitine in Type 2 Diabetes: DIABASI Randomized Controlled Trial.

Parvanova A, Trillini M, Podestà MA, Iliev IP, Aparicio C, Perna A, Peraro F, Rubis N, Gaspari F, Cannata A, Ferrari S, Bossi AC, Trevisan R, Parameswaran S, Chávez-Iñiguez JS, Masnic F, Seck SM, Jiamjariyaporn T, Cortinovis M, Perico L, Sharma K, Remuzzi G, Ruggenenti P, Warnock DG.

J Endocr Soc. 2018 Mar 22;2(5):420-436. doi: 10.1210/js.2017-00426. eCollection 2018 May 1.

23.

Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis.

Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, Rayner BL, Remuzzi G, Okpechi IG.

PLoS One. 2018 Apr 16;13(4):e0195443. doi: 10.1371/journal.pone.0195443. eCollection 2018. Review.

24.

The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational Study.

Jommi C, Armeni P, Battista M, di Procolo P, Conte G, Ronco C, Cozzolino M, Costanzo AM, di Luzio Paparatti U, Concas G, Remuzzi G; IRIDE Study Group.

Pharmacoecon Open. 2017 Dec 4. doi: 10.1007/s41669-017-0062-z. [Epub ahead of print]

25.

Early and late scanning electron microscopy findings in diabetic kidney disease.

Conti S, Perico N, Novelli R, Carrara C, Benigni A, Remuzzi G.

Sci Rep. 2018 Mar 20;8(1):4909. doi: 10.1038/s41598-018-23244-2.

26.

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Osborne AJ, Breno M, Borsa NG, Bu F, Frémeaux-Bacchi V, Gale DP, van den Heuvel LP, Kavanagh D, Noris M, Pinto S, Rallapalli PM, Remuzzi G, Rodríguez de Cordoba S, Ruiz A, Smith RJH, Vieira-Martins P, Volokhina E, Wilson V, Goodship THJ, Perkins SJ.

J Immunol. 2018 Apr 1;200(7):2464-2478. doi: 10.4049/jimmunol.1701695. Epub 2018 Mar 2.

PMID:
29500241
27.

Invited letter in response to: "Is the kidney donor profile index (KDPI) universal or UNOS-specific?"

Ruggenenti P, Remuzzi G.

Am J Transplant. 2018 Apr;18(4):1033-1034. doi: 10.1111/ajt.14652. Epub 2018 Feb 3. No abstract available.

PMID:
29316192
28.

Mesenchymal stromal cells for tolerance induction in organ transplantation.

Casiraghi F, Perico N, Remuzzi G.

Hum Immunol. 2018 May;79(5):304-313. doi: 10.1016/j.humimm.2017.12.008. Epub 2017 Dec 27. Review.

PMID:
29288697
29.

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.

Mc Causland FR, Claggett B, Pfeffer MA, Burdmann EA, Eckardt KU, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P.

Am J Nephrol. 2017;46(6):488-497. doi: 10.1159/000485326. Epub 2017 Dec 14.

PMID:
29241199
30.

Mesenchymal Stromal Cells for AKI after Cardiac Surgery.

Perico N, Casiraghi F, Remuzzi G.

J Am Soc Nephrol. 2018 Jan;29(1):7-9. doi: 10.1681/ASN.2017111207. Epub 2017 Dec 11. No abstract available.

PMID:
29229766
31.

Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

Perico N, Casiraghi F, Remuzzi G.

J Am Soc Nephrol. 2018 Feb;29(2):362-375. doi: 10.1681/ASN.2017070781. Epub 2017 Nov 30.

PMID:
29191959
32.

Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?

Noris M, Ruggenenti P, Remuzzi G.

Am J Kidney Dis. 2017 Dec;70(6):754-757. doi: 10.1053/j.ajkd.2017.08.005. No abstract available.

PMID:
29169515
33.

Chronic kidney disease.

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ.

Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88. Review.

PMID:
29168475
34.

Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.

Weldegiorgis M, de Zeeuw D, Li L, Parving HH, Hou FF, Remuzzi G, Greene T, Heerspink HJL.

Am J Kidney Dis. 2018 Jan;71(1):91-101. doi: 10.1053/j.ajkd.2017.08.010. Epub 2017 Nov 16.

PMID:
29153995
35.

Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.

Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5. Epub 2017 Nov 2.

PMID:
29104158
36.

Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries.

Anand S, Zheng Y, Montez-Rath ME, Wei WJ, Perico N, Carminati S, Narayan KV, Tandon N, Mohan V, Jha V, Zhang L, Remuzzi G, Prabahkaran D, Chertow GM.

BMJ Glob Health. 2017 Oct 9;2(4):e000453. doi: 10.1136/bmjgh-2017-000453. eCollection 2017.

37.

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function.

Perico L, Morigi M, Rota C, Breno M, Mele C, Noris M, Introna M, Capelli C, Longaretti L, Rottoli D, Conti S, Corna D, Remuzzi G, Benigni A.

Nat Commun. 2017 Oct 17;8(1):983. doi: 10.1038/s41467-017-00937-2.

38.

Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.

Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi.

J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13.

PMID:
29030465
39.

Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.

Goicoechea de Jorge E, Tortajada A, García SP, Gastoldi S, Merinero HM, García-Fernández J, Arjona E, Cao M, Remuzzi G, Noris M, Rodríguez de Córdoba S.

J Am Soc Nephrol. 2018 Jan;29(1):240-249. doi: 10.1681/ASN.2017050518. Epub 2017 Oct 9.

PMID:
28993505
40.

The Vatican-Mario Negri-Lancet Commission on the value of life.

Lee N, Remuzzi G, Horton R.

Lancet. 2017 Sep 30;390(10102):1573. doi: 10.1016/S0140-6736(17)32100-1. Epub 2017 Sep 28. No abstract available.

PMID:
28980947
41.

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.

Aiello S, Rocchetta F, Longaretti L, Faravelli S, Todeschini M, Cassis L, Pezzuto F, Tomasoni S, Azzollini N, Mister M, Mele C, Conti S, Breno M, Remuzzi G, Noris M, Benigni A.

Sci Rep. 2017 Sep 14;7(1):11518. doi: 10.1038/s41598-017-08617-3.

42.

Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement.

Noris M, Remuzzi G.

Semin Nephrol. 2017 Sep;37(5):447-463. doi: 10.1016/j.semnephrol.2017.05.018. Review.

PMID:
28863792
43.

Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.

Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, Brennan JJ, Houser M, Correa-Rotter R, Kohan D, Makino H, Perkovic V, Remuzzi G, Tobe SW, Toto R, Busch R, Pergola P, Parving HH, de Zeeuw D.

Drugs R D. 2017 Sep;17(3):441-448. doi: 10.1007/s40268-017-0201-0.

44.

The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular Diseases.

Rizzo P, Novelli R, Rota C, Gagliardini E, Ruggiero B, Rottoli D, Benigni A, Remuzzi G.

Am J Pathol. 2017 Nov;187(11):2441-2450. doi: 10.1016/j.ajpath.2017.07.004. Epub 2017 Aug 12.

PMID:
28807596
45.

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.

Legendre CM, Campistol JM, Feldkamp T, Remuzzi G, Kincaid JF, Lommelé Å, Wang J, Weekers LE, Sheerin NS.

Transpl Int. 2017 Dec;30(12):1275-1283. doi: 10.1111/tri.13022. Epub 2017 Sep 8.

PMID:
28801959
46.

Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study.

Ruggenenti P, Silvestre C, Boschiero L, Rota G, Furian L, Perna A, Rossini G, Remuzzi G, Rigotti P.

Am J Transplant. 2017 Dec;17(12):3159-3171. doi: 10.1111/ajt.14459. Epub 2017 Sep 15.

PMID:
28792681
47.

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V; TESTING Study Group.

JAMA. 2017 Aug 1;318(5):432-442. doi: 10.1001/jama.2017.9362.

48.

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Kikuchi M, Shobu Y.

Clin Exp Nephrol. 2018 Apr;22(2):299-308. doi: 10.1007/s10157-017-1447-0. Epub 2017 Jul 24.

49.

Therapeutic Plasma Exchange in Neonates and Infants: Successful Use of a Miniaturized Machine.

Vidal E, Garzotto F, Parolin M, Manenti C, Zanin A, Bellettato M, Remuzzi G, Goldstein SL, Murer L, Ronco C.

Blood Purif. 2017;44(2):100-105. doi: 10.1159/000470827. Epub 2017 Mar 31.

PMID:
28715820
50.

Acute Kidney Injury and Hemolytic Anemia Secondary to Mycoplasma pneumoniae Infection.

Carrara C, Abbate M, Sabadini E, Remuzzi G.

Nephron. 2017;137(2):148-154. doi: 10.1159/000478991. Epub 2017 Jul 7.

PMID:
28683450

Supplemental Content

Loading ...
Support Center